Compare First Citizens BancShares Inc (FCNCA) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs Cassava Sciences Inc — how do they compare? First Citizens BancShares Inc trades at $2,124.52 (market cap $23.76B), while Cassava Sciences Inc trades at $1.07 (market cap $53.14M). The key difference: First Citizens BancShares Inc is far larger — about 447.1× Cassava Sciences Inc's market cap, and First Citizens BancShares Inc pays a 0.41% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FCNCA | FLNA | |
|---|---|---|
Market Cap | $23.76B | $53.14M |
Sector | Sector/Thematic | Health |
52-Week High | $2.20K | $4.64 |
52-Week Low | $1.64K | $1.09 |
Dividend Yield | 0.41% | — |
Enterprise Value | — | -$33.43M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Filana Therapeutics (FLNA) trades at $1.09, down 5.22% on the day, reflecting persistent operational losses despite recent earnings beats. The stock exhibits a strong bearish technical signal, with moving averages and oscillators aligned negatively. Fundamentally, the company is in a pre-revenue biotech development phase, evidenced by significant negative cash flow from operations (-$32.25M in 2025) and deeply negative profitability metrics (ROE: -79.59%). Recent news highlights continued focus on its Tuberous Sclerosis Complex (TSC)-related epilepsy program.
The outlook is bifurcated: a bullish analyst consensus (8 Buy, 4 Hold, 0 Sell) suggests optimism for the clinical pipeline, while severe financial burn and bearish technicals present substantial near-term risk. Investment opportunity hinges entirely on successful drug development, with significant dilution or financing risk as the company funds operations. The stock is suitable only for high-risk investors comfortable with binary clinical outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
